Department of Chemistry, Jackson State University, Jackson, Mississippi, United States.
ACS Appl Mater Interfaces. 2011 Sep;3(9):3316-24. doi: 10.1021/am2004366. Epub 2011 Aug 26.
Breast cancer presents greatest challenge in health care in today's world. The key to ultimately successful treatment of breast cancer disease is an early and accurate diagnosis. Current breast cancer treatments are often associated with severe side effects. Driven by the need, we report the design of novel hybrid nanomaterial using gold nano popcorn-attached single wall carbon nanotube for targeted diagnosis and selective photothermal treatment. Targeted SK-BR-3 human breast cancer cell sensing have been performed in 10 cancer cells/mL level, using surface enhanced Raman scattering of single walls carbon nanotube's D and G bands. Our data show that S6 aptamer attached hybrid nanomaterial based SERS assay is highly sensitive to targeted human breast cancer SK-BR-3 cell line and it will be able to distinguish it from other non targeted MDA-MB breast cancer cell line and HaCaT normal skin cell line. Our results also show that 10 min of photothermal therapy treatment by 1.5 W/cm(2) power, 785 nm laser is enough to kill cancer cells very effectively using S6 aptamer attached hybrid nanomaterials. Possible mechanisms for targeted sensing and operating principle for highly efficient photothermal therapy have been discussed. Our experimental results reported here open up a new possibility for using aptamers modified hybrid nanomaterial for reliable diagnosis and targeted therapy of cancer cell lines quickly.
在当今世界,乳腺癌是医疗保健领域面临的最大挑战。乳腺癌疾病最终成功治疗的关键在于早期、准确的诊断。目前的乳腺癌治疗方法常常伴随着严重的副作用。受此需求驱动,我们报告了一种新型杂化纳米材料的设计,该材料使用金纳米爆米花附着的单壁碳纳米管用于靶向诊断和选择性光热治疗。使用单壁碳纳米管的 D 和 G 带的表面增强拉曼散射,在 10 个癌细胞/mL 水平上对靶向 SK-BR-3 人乳腺癌细胞进行了检测。我们的数据表明,基于 S6 适体的杂交纳米材料的 SERS 测定法对靶向人乳腺癌 SK-BR-3 细胞系具有高度敏感性,并且能够将其与其他非靶向 MDA-MB 乳腺癌细胞系和 HaCaT 正常皮肤细胞系区分开来。我们的结果还表明,使用 S6 适体附着的杂交纳米材料,通过 1.5 W/cm(2)功率、785nm 激光进行 10 分钟的光热治疗足以非常有效地杀死癌细胞。我们讨论了靶向传感的可能机制和高效光热治疗的工作原理。我们在这里报告的实验结果为使用适体修饰的杂化纳米材料快速可靠地诊断和靶向治疗癌细胞系开辟了新的可能性。